Cardiovascular Pathology in Hyperlipoproteinemia (HLP).

Abstract

Meeting Abstracts1 May 1973Cardiovascular Pathology in Hyperlipoproteinemia (HLP).William C. Roberts, M.D., Victor J. Ferrans, M.D., Robert I. Levy, M.D., F.A.C.P., Donald S. Fredrickson, M.D., F.A.C.P.William C. Roberts, M.D.Search for more papers by this author, Victor J. Ferrans, M.D.Search for more papers by this author, Robert I. Levy, M.D., F.A.C.P.Search for more papers by this author, Donald S. Fredrickson, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-78-5-820_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptLittle information is available on the morphologic aspects of hyperlipoproteinemia. To begin to fill this void 28 patients known to have this disorder and 14 with normal lipoprotein patterns were studied at necropsy. Of the 42 patients, 28 had symptomatic ischemic heart disease—20 of these had hyperlipoproteinemia (type II, 9; type III, 2; type IV, 9), and 8 had normal lipoproteins. The average age at death in the 20 patients with hyperlipoproteinemia and symptomatic heart disease was 48 years; in the 8 with normal lipoproteins, 46 years. The degree of coronary arterial luminal narrowing was severe in all with heart... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Bethesda, Maryland PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1973Volume 78, Issue 5Page: 820-820KeywordsCardiovascular therapyHeartLipoproteins Issue Published: 1 May 1973 PDF downloadLoading ...